Glaucoma Treatment by Circular Cyclocoagulation Using High Intensity Focused Ultrasound With the EYEOP Medical Device

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

52 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-04-30

Study Completion Date

2013-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to evaluate the effectiveness and the safety of the EYEOP treatment using High Intensity Focused Ultrasound in refractory glaucoma patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Circular Cyclocoagulation Using HIFU With EYEOP1 Device in Glaucoma Patients

NCT01791673

Glaucoma

COMPLETED NA

Glaucoma Treatment by Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU)

NCT01592955

Glaucoma

COMPLETED PHASE4

Ocular Fluorophotometry for Glaucoma Treated With Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU).

NCT01908985

Refractory Open Angle Glaucoma

NO_LONGER_AVAILABLE

Glaucoma Treatment Using Focused Ultrasound in Open Angle Glaucoma Patients

NCT02789293

Glaucoma

COMPLETED NA

Cyclophotocoagulation in Primary Open Angle Glaucoma

NCT04430296

Primary Open Angle Glaucoma

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glaucoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

EYEOP Treatment

Open label, all subject treated by the EYEOP device

Group Type EXPERIMENTAL

EYEOP device

Intervention Type DEVICE

Cyclocoagulation using High Intensity Focused Ultrasound with EYEOP device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EYEOP device

Cyclocoagulation using High Intensity Focused Ultrasound with EYEOP device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary open angle glaucoma included pseudo-exfoliative glaucoma and pigmentary glaucoma in the study eye with maximally tolerated medical treatment
* Ocular hypertension defined as an intraocular pressure (IOP) \> 21 mm Hg
* Subject has failed a conventional intraocular glaucoma filtering surgery
* Patient must be aged 18 years or more
* No previous intraocular glaucoma surgery or laser treatment in the study eye during the 3 months before HIFU treatment
* No previous cyclophotocoagulation procedure in the study eye
* Patient able and willing to provide informed consent and to complete post-operative follow-up requirements.

Exclusion Criteria

* History of previous glaucoma surgery with implantation of glaucoma drainage device in the study eye
* History of ocular or retrobulbar tumor
* Retinal detachment, choroidal hemorrhage or detachment
* Ocular infectious disease within 14 days before HIFU treatment

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No